Categories AlphaGraphs, Earnings, Finance

360 Finance (QFIN) Q2 earnings rise as revenues surge 50%

Total loan origination volume increased by 22%, with loan volume under the capital-light model within Platform Services more than tripling

China-based consumer finance company 360 Finance, Inc. (NASDAQ: QFIN) reported a marked increase in second-quarter earnings, aided by double-digit growth in revenues. The company’s stock was trading up 3.4% early Monday, following the announcement.

360 Finance Q2 2020 Earnings Infographic

Earnings, on an adjusted basis, rose to RMB 942.1 million ($133.4 million) or RMB 6.19 per ADS ($0.88 per ADS) from RMB 691.7 million or RMB 4.56 per ADS in the second quarter of 2019. Unadjusted net earnings climbed 41.8% year-over-year to RMB 876.5 million ($124.1 million).

The bottom-line benefitted from a 50% growth in revenues to RMB 3.34 billion ($472.8 million), with Credit Driven Services and Platform Services increasing 53% and 22%, respectively. At RMB 58.9 billion, total loan origination volume was up 22% from last year, reflecting a strong contribution from Platform Services.

“We are very excited to report a series of record-breaking financial and operational metrics for the second quarter of 2020 despite the still challenging macro environment. Loan origination volume reached a record RMB58.9 billion, an increase of 22% year-on-year,” said CEO Haisheng Wu.

Looking forward to listening to management/analysts’ comments on Q2 results? Stay tuned here for 360 Finance’s Q2 2020 earnings call transcript 

360 Finance will be holding an extraordinary general meeting of shareholders on September 15 to seek shareholders’ approval for its plan to change the company’s name to “360 DigiTech Inc.”

Soon after the earnings announcement, shares of the company rose sharply in Monday’s pre-market trading at the Nasdaq stock exchange, after closing the previous session higher.

_______

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top